nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoversetamide—Chest pain—Paclitaxel—kidney cancer	0.00049	0.00049	CcSEcCtD
Gadoversetamide—Mediastinal disorder—Capecitabine—kidney cancer	0.000489	0.000489	CcSEcCtD
Gadoversetamide—Anxiety—Paclitaxel—kidney cancer	0.000488	0.000488	CcSEcCtD
Gadoversetamide—Face oedema—Doxorubicin—kidney cancer	0.000488	0.000488	CcSEcCtD
Gadoversetamide—Decreased appetite—Gemcitabine—kidney cancer	0.000488	0.000488	CcSEcCtD
Gadoversetamide—Hypersensitivity—Dactinomycin—kidney cancer	0.000488	0.000488	CcSEcCtD
Gadoversetamide—Chills—Capecitabine—kidney cancer	0.000487	0.000487	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000487	0.000487	CcSEcCtD
Gadoversetamide—Arrhythmia—Capecitabine—kidney cancer	0.000485	0.000485	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000484	0.000484	CcSEcCtD
Gadoversetamide—Discomfort—Paclitaxel—kidney cancer	0.000484	0.000484	CcSEcCtD
Gadoversetamide—Fatigue—Gemcitabine—kidney cancer	0.000484	0.000484	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Vincristine—kidney cancer	0.000484	0.000484	CcSEcCtD
Gadoversetamide—Dizziness—Sorafenib—kidney cancer	0.00048	0.00048	CcSEcCtD
Gadoversetamide—Constipation—Gemcitabine—kidney cancer	0.00048	0.00048	CcSEcCtD
Gadoversetamide—Pain—Gemcitabine—kidney cancer	0.00048	0.00048	CcSEcCtD
Gadoversetamide—Nausea—Erlotinib—kidney cancer	0.00048	0.00048	CcSEcCtD
Gadoversetamide—Dry mouth—Paclitaxel—kidney cancer	0.000479	0.000479	CcSEcCtD
Gadoversetamide—Diarrhoea—Sunitinib—kidney cancer	0.000478	0.000478	CcSEcCtD
Gadoversetamide—Mental disorder—Capecitabine—kidney cancer	0.000475	0.000475	CcSEcCtD
Gadoversetamide—Asthenia—Dactinomycin—kidney cancer	0.000475	0.000475	CcSEcCtD
Gadoversetamide—Confusional state—Paclitaxel—kidney cancer	0.000474	0.000474	CcSEcCtD
Gadoversetamide—Blood creatinine increased—Doxorubicin—kidney cancer	0.000474	0.000474	CcSEcCtD
Gadoversetamide—Erythema—Capecitabine—kidney cancer	0.000472	0.000472	CcSEcCtD
Gadoversetamide—Malnutrition—Capecitabine—kidney cancer	0.000472	0.000472	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Paclitaxel—kidney cancer	0.00047	0.00047	CcSEcCtD
Gadoversetamide—Oedema—Paclitaxel—kidney cancer	0.00047	0.00047	CcSEcCtD
Gadoversetamide—Body temperature increased—Vincristine—kidney cancer	0.000467	0.000467	CcSEcCtD
Gadoversetamide—Abdominal pain—Vincristine—kidney cancer	0.000467	0.000467	CcSEcCtD
Gadoversetamide—Flatulence—Capecitabine—kidney cancer	0.000465	0.000465	CcSEcCtD
Gadoversetamide—Dry skin—Doxorubicin—kidney cancer	0.000463	0.000463	CcSEcCtD
Gadoversetamide—Dysgeusia—Capecitabine—kidney cancer	0.000462	0.000462	CcSEcCtD
Gadoversetamide—Dizziness—Sunitinib—kidney cancer	0.000462	0.000462	CcSEcCtD
Gadoversetamide—Feeling abnormal—Gemcitabine—kidney cancer	0.000462	0.000462	CcSEcCtD
Gadoversetamide—Shock—Paclitaxel—kidney cancer	0.000462	0.000462	CcSEcCtD
Gadoversetamide—Vomiting—Sorafenib—kidney cancer	0.000462	0.000462	CcSEcCtD
Gadoversetamide—Nervous system disorder—Paclitaxel—kidney cancer	0.000461	0.000461	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Paclitaxel—kidney cancer	0.00046	0.00046	CcSEcCtD
Gadoversetamide—Tachycardia—Paclitaxel—kidney cancer	0.000458	0.000458	CcSEcCtD
Gadoversetamide—Rash—Sorafenib—kidney cancer	0.000458	0.000458	CcSEcCtD
Gadoversetamide—Dermatitis—Sorafenib—kidney cancer	0.000458	0.000458	CcSEcCtD
Gadoversetamide—Back pain—Capecitabine—kidney cancer	0.000457	0.000457	CcSEcCtD
Gadoversetamide—Skin disorder—Paclitaxel—kidney cancer	0.000456	0.000456	CcSEcCtD
Gadoversetamide—Headache—Sorafenib—kidney cancer	0.000455	0.000455	CcSEcCtD
Gadoversetamide—Muscle spasms—Capecitabine—kidney cancer	0.000454	0.000454	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Paclitaxel—kidney cancer	0.000454	0.000454	CcSEcCtD
Gadoversetamide—Diarrhoea—Dactinomycin—kidney cancer	0.000453	0.000453	CcSEcCtD
Gadoversetamide—Nasopharyngitis—Doxorubicin—kidney cancer	0.000452	0.000452	CcSEcCtD
Gadoversetamide—Anorexia—Paclitaxel—kidney cancer	0.000448	0.000448	CcSEcCtD
Gadoversetamide—Muscular weakness—Doxorubicin—kidney cancer	0.000446	0.000446	CcSEcCtD
Gadoversetamide—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000446	0.000446	CcSEcCtD
Gadoversetamide—Vision blurred—Capecitabine—kidney cancer	0.000445	0.000445	CcSEcCtD
Gadoversetamide—Vomiting—Sunitinib—kidney cancer	0.000444	0.000444	CcSEcCtD
Gadoversetamide—Body temperature increased—Gemcitabine—kidney cancer	0.000443	0.000443	CcSEcCtD
Gadoversetamide—Tremor—Capecitabine—kidney cancer	0.000442	0.000442	CcSEcCtD
Gadoversetamide—Rash—Sunitinib—kidney cancer	0.000441	0.000441	CcSEcCtD
Gadoversetamide—Dermatitis—Sunitinib—kidney cancer	0.00044	0.00044	CcSEcCtD
Gadoversetamide—Hypotension—Paclitaxel—kidney cancer	0.000439	0.000439	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Capecitabine—kidney cancer	0.000438	0.000438	CcSEcCtD
Gadoversetamide—Headache—Sunitinib—kidney cancer	0.000438	0.000438	CcSEcCtD
Gadoversetamide—Dysphagia—Doxorubicin—kidney cancer	0.000437	0.000437	CcSEcCtD
Gadoversetamide—Asthma—Doxorubicin—kidney cancer	0.000437	0.000437	CcSEcCtD
Gadoversetamide—Influenza—Doxorubicin—kidney cancer	0.000437	0.000437	CcSEcCtD
Gadoversetamide—Hypersensitivity—Vincristine—kidney cancer	0.000436	0.000436	CcSEcCtD
Gadoversetamide—Nausea—Sorafenib—kidney cancer	0.000432	0.000432	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000428	0.000428	CcSEcCtD
Gadoversetamide—Malaise—Capecitabine—kidney cancer	0.000426	0.000426	CcSEcCtD
Gadoversetamide—Insomnia—Paclitaxel—kidney cancer	0.000425	0.000425	CcSEcCtD
Gadoversetamide—Vertigo—Capecitabine—kidney cancer	0.000424	0.000424	CcSEcCtD
Gadoversetamide—Asthenia—Vincristine—kidney cancer	0.000424	0.000424	CcSEcCtD
Gadoversetamide—Syncope—Capecitabine—kidney cancer	0.000423	0.000423	CcSEcCtD
Gadoversetamide—Paraesthesia—Paclitaxel—kidney cancer	0.000422	0.000422	CcSEcCtD
Gadoversetamide—Vomiting—Dactinomycin—kidney cancer	0.000421	0.000421	CcSEcCtD
Gadoversetamide—Dyspnoea—Paclitaxel—kidney cancer	0.000419	0.000419	CcSEcCtD
Gadoversetamide—Somnolence—Paclitaxel—kidney cancer	0.000418	0.000418	CcSEcCtD
Gadoversetamide—Palpitations—Capecitabine—kidney cancer	0.000417	0.000417	CcSEcCtD
Gadoversetamide—Rash—Dactinomycin—kidney cancer	0.000417	0.000417	CcSEcCtD
Gadoversetamide—Nausea—Sunitinib—kidney cancer	0.000415	0.000415	CcSEcCtD
Gadoversetamide—Loss of consciousness—Capecitabine—kidney cancer	0.000415	0.000415	CcSEcCtD
Gadoversetamide—Dyspepsia—Paclitaxel—kidney cancer	0.000413	0.000413	CcSEcCtD
Gadoversetamide—Cough—Capecitabine—kidney cancer	0.000412	0.000412	CcSEcCtD
Gadoversetamide—Dysuria—Doxorubicin—kidney cancer	0.000409	0.000409	CcSEcCtD
Gadoversetamide—Decreased appetite—Paclitaxel—kidney cancer	0.000408	0.000408	CcSEcCtD
Gadoversetamide—Hypertension—Capecitabine—kidney cancer	0.000408	0.000408	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000405	0.000405	CcSEcCtD
Gadoversetamide—Fatigue—Paclitaxel—kidney cancer	0.000405	0.000405	CcSEcCtD
Gadoversetamide—Diarrhoea—Vincristine—kidney cancer	0.000405	0.000405	CcSEcCtD
Gadoversetamide—Asthenia—Gemcitabine—kidney cancer	0.000402	0.000402	CcSEcCtD
Gadoversetamide—Arthralgia—Capecitabine—kidney cancer	0.000402	0.000402	CcSEcCtD
Gadoversetamide—Chest pain—Capecitabine—kidney cancer	0.000402	0.000402	CcSEcCtD
Gadoversetamide—Myalgia—Capecitabine—kidney cancer	0.000402	0.000402	CcSEcCtD
Gadoversetamide—Constipation—Paclitaxel—kidney cancer	0.000402	0.000402	CcSEcCtD
Gadoversetamide—Pain—Paclitaxel—kidney cancer	0.000402	0.000402	CcSEcCtD
Gadoversetamide—Anxiety—Capecitabine—kidney cancer	0.000401	0.000401	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000399	0.000399	CcSEcCtD
Gadoversetamide—Discomfort—Capecitabine—kidney cancer	0.000397	0.000397	CcSEcCtD
Gadoversetamide—Pruritus—Gemcitabine—kidney cancer	0.000397	0.000397	CcSEcCtD
Gadoversetamide—Hyperglycaemia—Doxorubicin—kidney cancer	0.000394	0.000394	CcSEcCtD
Gadoversetamide—Dry mouth—Capecitabine—kidney cancer	0.000393	0.000393	CcSEcCtD
Gadoversetamide—Nausea—Dactinomycin—kidney cancer	0.000393	0.000393	CcSEcCtD
Gadoversetamide—Pneumonia—Doxorubicin—kidney cancer	0.000392	0.000392	CcSEcCtD
Gadoversetamide—Dizziness—Vincristine—kidney cancer	0.000391	0.000391	CcSEcCtD
Gadoversetamide—Confusional state—Capecitabine—kidney cancer	0.000389	0.000389	CcSEcCtD
Gadoversetamide—Feeling abnormal—Paclitaxel—kidney cancer	0.000387	0.000387	CcSEcCtD
Gadoversetamide—Oedema—Capecitabine—kidney cancer	0.000385	0.000385	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000384	0.000384	CcSEcCtD
Gadoversetamide—Diarrhoea—Gemcitabine—kidney cancer	0.000384	0.000384	CcSEcCtD
Gadoversetamide—Shock—Capecitabine—kidney cancer	0.000379	0.000379	CcSEcCtD
Gadoversetamide—Urinary tract infection—Doxorubicin—kidney cancer	0.000379	0.000379	CcSEcCtD
Gadoversetamide—Conjunctivitis—Doxorubicin—kidney cancer	0.000379	0.000379	CcSEcCtD
Gadoversetamide—Nervous system disorder—Capecitabine—kidney cancer	0.000378	0.000378	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Capecitabine—kidney cancer	0.000377	0.000377	CcSEcCtD
Gadoversetamide—Tachycardia—Capecitabine—kidney cancer	0.000376	0.000376	CcSEcCtD
Gadoversetamide—Vomiting—Vincristine—kidney cancer	0.000376	0.000376	CcSEcCtD
Gadoversetamide—Skin disorder—Capecitabine—kidney cancer	0.000374	0.000374	CcSEcCtD
Gadoversetamide—Urticaria—Paclitaxel—kidney cancer	0.000373	0.000373	CcSEcCtD
Gadoversetamide—Rash—Vincristine—kidney cancer	0.000373	0.000373	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Capecitabine—kidney cancer	0.000373	0.000373	CcSEcCtD
Gadoversetamide—Dermatitis—Vincristine—kidney cancer	0.000372	0.000372	CcSEcCtD
Gadoversetamide—Haematuria—Doxorubicin—kidney cancer	0.000371	0.000371	CcSEcCtD
Gadoversetamide—Abdominal pain—Paclitaxel—kidney cancer	0.000371	0.000371	CcSEcCtD
Gadoversetamide—Body temperature increased—Paclitaxel—kidney cancer	0.000371	0.000371	CcSEcCtD
Gadoversetamide—Headache—Vincristine—kidney cancer	0.00037	0.00037	CcSEcCtD
Gadoversetamide—Epistaxis—Doxorubicin—kidney cancer	0.000367	0.000367	CcSEcCtD
Gadoversetamide—Anorexia—Capecitabine—kidney cancer	0.000367	0.000367	CcSEcCtD
Gadoversetamide—Sinusitis—Doxorubicin—kidney cancer	0.000365	0.000365	CcSEcCtD
Gadoversetamide—Hypotension—Capecitabine—kidney cancer	0.00036	0.00036	CcSEcCtD
Gadoversetamide—Vomiting—Gemcitabine—kidney cancer	0.000357	0.000357	CcSEcCtD
Gadoversetamide—Rash—Gemcitabine—kidney cancer	0.000354	0.000354	CcSEcCtD
Gadoversetamide—Dermatitis—Gemcitabine—kidney cancer	0.000353	0.000353	CcSEcCtD
Gadoversetamide—Haemoglobin—Doxorubicin—kidney cancer	0.000351	0.000351	CcSEcCtD
Gadoversetamide—Headache—Gemcitabine—kidney cancer	0.000351	0.000351	CcSEcCtD
Gadoversetamide—Nausea—Vincristine—kidney cancer	0.000351	0.000351	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000351	0.000351	CcSEcCtD
Gadoversetamide—Rhinitis—Doxorubicin—kidney cancer	0.000351	0.000351	CcSEcCtD
Gadoversetamide—Haemorrhage—Doxorubicin—kidney cancer	0.00035	0.00035	CcSEcCtD
Gadoversetamide—Insomnia—Capecitabine—kidney cancer	0.000349	0.000349	CcSEcCtD
Gadoversetamide—Hypoaesthesia—Doxorubicin—kidney cancer	0.000348	0.000348	CcSEcCtD
Gadoversetamide—Pharyngitis—Doxorubicin—kidney cancer	0.000347	0.000347	CcSEcCtD
Gadoversetamide—Paraesthesia—Capecitabine—kidney cancer	0.000346	0.000346	CcSEcCtD
Gadoversetamide—Hypersensitivity—Paclitaxel—kidney cancer	0.000346	0.000346	CcSEcCtD
Gadoversetamide—Urinary tract disorder—Doxorubicin—kidney cancer	0.000345	0.000345	CcSEcCtD
Gadoversetamide—Oedema peripheral—Doxorubicin—kidney cancer	0.000344	0.000344	CcSEcCtD
Gadoversetamide—Dyspnoea—Capecitabine—kidney cancer	0.000344	0.000344	CcSEcCtD
Gadoversetamide—Urethral disorder—Doxorubicin—kidney cancer	0.000343	0.000343	CcSEcCtD
Gadoversetamide—Dyspepsia—Capecitabine—kidney cancer	0.000339	0.000339	CcSEcCtD
Gadoversetamide—Asthenia—Paclitaxel—kidney cancer	0.000337	0.000337	CcSEcCtD
Gadoversetamide—Decreased appetite—Capecitabine—kidney cancer	0.000335	0.000335	CcSEcCtD
Gadoversetamide—Nausea—Gemcitabine—kidney cancer	0.000333	0.000333	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000333	0.000333	CcSEcCtD
Gadoversetamide—Fatigue—Capecitabine—kidney cancer	0.000332	0.000332	CcSEcCtD
Gadoversetamide—Pruritus—Paclitaxel—kidney cancer	0.000332	0.000332	CcSEcCtD
Gadoversetamide—Erythema multiforme—Doxorubicin—kidney cancer	0.000331	0.000331	CcSEcCtD
Gadoversetamide—Constipation—Capecitabine—kidney cancer	0.00033	0.00033	CcSEcCtD
Gadoversetamide—Pain—Capecitabine—kidney cancer	0.00033	0.00033	CcSEcCtD
Gadoversetamide—Eye disorder—Doxorubicin—kidney cancer	0.000327	0.000327	CcSEcCtD
Gadoversetamide—Tinnitus—Doxorubicin—kidney cancer	0.000326	0.000326	CcSEcCtD
Gadoversetamide—Flushing—Doxorubicin—kidney cancer	0.000325	0.000325	CcSEcCtD
Gadoversetamide—Cardiac disorder—Doxorubicin—kidney cancer	0.000325	0.000325	CcSEcCtD
Gadoversetamide—Diarrhoea—Paclitaxel—kidney cancer	0.000321	0.000321	CcSEcCtD
Gadoversetamide—Feeling abnormal—Capecitabine—kidney cancer	0.000318	0.000318	CcSEcCtD
Gadoversetamide—Angiopathy—Doxorubicin—kidney cancer	0.000317	0.000317	CcSEcCtD
Gadoversetamide—Immune system disorder—Doxorubicin—kidney cancer	0.000316	0.000316	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Capecitabine—kidney cancer	0.000315	0.000315	CcSEcCtD
Gadoversetamide—Mediastinal disorder—Doxorubicin—kidney cancer	0.000315	0.000315	CcSEcCtD
Gadoversetamide—Chills—Doxorubicin—kidney cancer	0.000314	0.000314	CcSEcCtD
Gadoversetamide—Arrhythmia—Doxorubicin—kidney cancer	0.000312	0.000312	CcSEcCtD
Gadoversetamide—Dizziness—Paclitaxel—kidney cancer	0.000311	0.000311	CcSEcCtD
Gadoversetamide—Mental disorder—Doxorubicin—kidney cancer	0.000306	0.000306	CcSEcCtD
Gadoversetamide—Urticaria—Capecitabine—kidney cancer	0.000306	0.000306	CcSEcCtD
Gadoversetamide—Abdominal pain—Capecitabine—kidney cancer	0.000305	0.000305	CcSEcCtD
Gadoversetamide—Body temperature increased—Capecitabine—kidney cancer	0.000305	0.000305	CcSEcCtD
Gadoversetamide—Malnutrition—Doxorubicin—kidney cancer	0.000304	0.000304	CcSEcCtD
Gadoversetamide—Erythema—Doxorubicin—kidney cancer	0.000304	0.000304	CcSEcCtD
Gadoversetamide—Flatulence—Doxorubicin—kidney cancer	0.0003	0.0003	CcSEcCtD
Gadoversetamide—Tension—Doxorubicin—kidney cancer	0.000299	0.000299	CcSEcCtD
Gadoversetamide—Vomiting—Paclitaxel—kidney cancer	0.000299	0.000299	CcSEcCtD
Gadoversetamide—Dysgeusia—Doxorubicin—kidney cancer	0.000298	0.000298	CcSEcCtD
Gadoversetamide—Rash—Paclitaxel—kidney cancer	0.000296	0.000296	CcSEcCtD
Gadoversetamide—Dermatitis—Paclitaxel—kidney cancer	0.000296	0.000296	CcSEcCtD
Gadoversetamide—Nervousness—Doxorubicin—kidney cancer	0.000296	0.000296	CcSEcCtD
Gadoversetamide—Back pain—Doxorubicin—kidney cancer	0.000294	0.000294	CcSEcCtD
Gadoversetamide—Headache—Paclitaxel—kidney cancer	0.000294	0.000294	CcSEcCtD
Gadoversetamide—Muscle spasms—Doxorubicin—kidney cancer	0.000293	0.000293	CcSEcCtD
Gadoversetamide—Vision blurred—Doxorubicin—kidney cancer	0.000287	0.000287	CcSEcCtD
Gadoversetamide—Hypersensitivity—Capecitabine—kidney cancer	0.000284	0.000284	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Doxorubicin—kidney cancer	0.000282	0.000282	CcSEcCtD
Gadoversetamide—Agitation—Doxorubicin—kidney cancer	0.00028	0.00028	CcSEcCtD
Gadoversetamide—Nausea—Paclitaxel—kidney cancer	0.000279	0.000279	CcSEcCtD
Gadoversetamide—Asthenia—Capecitabine—kidney cancer	0.000277	0.000277	CcSEcCtD
Gadoversetamide—Malaise—Doxorubicin—kidney cancer	0.000275	0.000275	CcSEcCtD
Gadoversetamide—Vertigo—Doxorubicin—kidney cancer	0.000273	0.000273	CcSEcCtD
Gadoversetamide—Syncope—Doxorubicin—kidney cancer	0.000273	0.000273	CcSEcCtD
Gadoversetamide—Pruritus—Capecitabine—kidney cancer	0.000273	0.000273	CcSEcCtD
Gadoversetamide—Palpitations—Doxorubicin—kidney cancer	0.000269	0.000269	CcSEcCtD
Gadoversetamide—Loss of consciousness—Doxorubicin—kidney cancer	0.000268	0.000268	CcSEcCtD
Gadoversetamide—Cough—Doxorubicin—kidney cancer	0.000266	0.000266	CcSEcCtD
Gadoversetamide—Convulsion—Doxorubicin—kidney cancer	0.000264	0.000264	CcSEcCtD
Gadoversetamide—Diarrhoea—Capecitabine—kidney cancer	0.000264	0.000264	CcSEcCtD
Gadoversetamide—Hypertension—Doxorubicin—kidney cancer	0.000263	0.000263	CcSEcCtD
Gadoversetamide—Arthralgia—Doxorubicin—kidney cancer	0.000259	0.000259	CcSEcCtD
Gadoversetamide—Myalgia—Doxorubicin—kidney cancer	0.000259	0.000259	CcSEcCtD
Gadoversetamide—Chest pain—Doxorubicin—kidney cancer	0.000259	0.000259	CcSEcCtD
Gadoversetamide—Anxiety—Doxorubicin—kidney cancer	0.000258	0.000258	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000257	0.000257	CcSEcCtD
Gadoversetamide—Discomfort—Doxorubicin—kidney cancer	0.000256	0.000256	CcSEcCtD
Gadoversetamide—Dizziness—Capecitabine—kidney cancer	0.000255	0.000255	CcSEcCtD
Gadoversetamide—Dry mouth—Doxorubicin—kidney cancer	0.000253	0.000253	CcSEcCtD
Gadoversetamide—Confusional state—Doxorubicin—kidney cancer	0.000251	0.000251	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Doxorubicin—kidney cancer	0.000248	0.000248	CcSEcCtD
Gadoversetamide—Oedema—Doxorubicin—kidney cancer	0.000248	0.000248	CcSEcCtD
Gadoversetamide—Vomiting—Capecitabine—kidney cancer	0.000245	0.000245	CcSEcCtD
Gadoversetamide—Shock—Doxorubicin—kidney cancer	0.000244	0.000244	CcSEcCtD
Gadoversetamide—Nervous system disorder—Doxorubicin—kidney cancer	0.000244	0.000244	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Doxorubicin—kidney cancer	0.000243	0.000243	CcSEcCtD
Gadoversetamide—Rash—Capecitabine—kidney cancer	0.000243	0.000243	CcSEcCtD
Gadoversetamide—Dermatitis—Capecitabine—kidney cancer	0.000243	0.000243	CcSEcCtD
Gadoversetamide—Tachycardia—Doxorubicin—kidney cancer	0.000242	0.000242	CcSEcCtD
Gadoversetamide—Headache—Capecitabine—kidney cancer	0.000241	0.000241	CcSEcCtD
Gadoversetamide—Skin disorder—Doxorubicin—kidney cancer	0.000241	0.000241	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Doxorubicin—kidney cancer	0.00024	0.00024	CcSEcCtD
Gadoversetamide—Anorexia—Doxorubicin—kidney cancer	0.000237	0.000237	CcSEcCtD
Gadoversetamide—Hypotension—Doxorubicin—kidney cancer	0.000232	0.000232	CcSEcCtD
Gadoversetamide—Nausea—Capecitabine—kidney cancer	0.000229	0.000229	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000226	0.000226	CcSEcCtD
Gadoversetamide—Insomnia—Doxorubicin—kidney cancer	0.000225	0.000225	CcSEcCtD
Gadoversetamide—Paraesthesia—Doxorubicin—kidney cancer	0.000223	0.000223	CcSEcCtD
Gadoversetamide—Dyspnoea—Doxorubicin—kidney cancer	0.000221	0.000221	CcSEcCtD
Gadoversetamide—Somnolence—Doxorubicin—kidney cancer	0.000221	0.000221	CcSEcCtD
Gadoversetamide—Dyspepsia—Doxorubicin—kidney cancer	0.000219	0.000219	CcSEcCtD
Gadoversetamide—Decreased appetite—Doxorubicin—kidney cancer	0.000216	0.000216	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000214	0.000214	CcSEcCtD
Gadoversetamide—Fatigue—Doxorubicin—kidney cancer	0.000214	0.000214	CcSEcCtD
Gadoversetamide—Pain—Doxorubicin—kidney cancer	0.000212	0.000212	CcSEcCtD
Gadoversetamide—Constipation—Doxorubicin—kidney cancer	0.000212	0.000212	CcSEcCtD
Gadoversetamide—Feeling abnormal—Doxorubicin—kidney cancer	0.000205	0.000205	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000203	0.000203	CcSEcCtD
Gadoversetamide—Urticaria—Doxorubicin—kidney cancer	0.000197	0.000197	CcSEcCtD
Gadoversetamide—Body temperature increased—Doxorubicin—kidney cancer	0.000196	0.000196	CcSEcCtD
Gadoversetamide—Abdominal pain—Doxorubicin—kidney cancer	0.000196	0.000196	CcSEcCtD
Gadoversetamide—Hypersensitivity—Doxorubicin—kidney cancer	0.000183	0.000183	CcSEcCtD
Gadoversetamide—Asthenia—Doxorubicin—kidney cancer	0.000178	0.000178	CcSEcCtD
Gadoversetamide—Pruritus—Doxorubicin—kidney cancer	0.000176	0.000176	CcSEcCtD
Gadoversetamide—Diarrhoea—Doxorubicin—kidney cancer	0.00017	0.00017	CcSEcCtD
Gadoversetamide—Dizziness—Doxorubicin—kidney cancer	0.000164	0.000164	CcSEcCtD
Gadoversetamide—Vomiting—Doxorubicin—kidney cancer	0.000158	0.000158	CcSEcCtD
Gadoversetamide—Rash—Doxorubicin—kidney cancer	0.000157	0.000157	CcSEcCtD
Gadoversetamide—Dermatitis—Doxorubicin—kidney cancer	0.000156	0.000156	CcSEcCtD
Gadoversetamide—Headache—Doxorubicin—kidney cancer	0.000156	0.000156	CcSEcCtD
Gadoversetamide—Nausea—Doxorubicin—kidney cancer	0.000148	0.000148	CcSEcCtD
